Trump Administration
Refine search
Biosimilars
US lawmakers have introduced bipartisan legislation that would reduce routine reliance on comparative clinical efficacy studies in biosimilar approvals, a move welcomed by the Association for Accessible Medicines (AAM) and its Biosimilars Council. 16 July 2026
Biotechnology
The US Department of Health and Human Services has launched a department-wide clinical trials reform initiative aimed at accelerating drug development, reducing unnecessary regulatory burden and reinforcing the USA’s position in global biomedical research. 23 June 2026
Pharmaceutical
The US Trade Representative (USTR) has launched a Section 301 investigation into Germany’s pharmaceutical pricing policies, escalating a dispute over how the costs of innovative medicines are shared between the USA and other wealthy markets. 22 June 2026
Biotechnology
Chinese life sciences services group WuXi AppTec has sued the US government over its inclusion on a Pentagon list of companies alleged to have links to China’s military, escalating a dispute with potentially wide implications for pharma outsourcing. 22 June 2026
Pharmaceutical
Jeffery Taubenberger, the acting director of the US National Institute of Allergy and Infectious Diseases (NIAID), has stepped down from the role, according to reports citing congressional Democrats and sources familiar with the matter. 22 May 2026
Pharmaceutical
New US tariff measures and acute geopolitical tensions are reshaping the global pharmaceutical landscape, prompting companies to rethink supply chains and production strategies, says intelligence and productivity platform. GlobalData. 8 May 2026
Pharmaceutical
US President Donald Trump on April 18 issued an Executive Order directing the US Department of Health and Human Services to accelerate access to treatments for patients with serious mental illness, including devastating, complex, and treatment-resistant conditions. 25 April 2026
Pharmaceutical
US President Donald Trump has nominated Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC) after a long search for a replacement for Susan Monarez, who was sacked in August last year. 17 April 2026
Pharmaceutical
The number of drug launches in Europe has fallen by around 35% in the 10 months since the USA introduced a new drug pricing policy, according to an analysis by the international research agency GlobalData. The figures are serious for European patients, says the Danish pharma trade group Lif. 13 April 2026
Pharmaceutical
Pharma trade group Medicines Australia says that, along with its members, it supports free, fair, and open trade and firmly oppose the proposed introduction of 100% tariffs on Australian branded and patented medicines exported to the USA. 10 April 2026
Pharmaceutical
Stephen Ubl will step down as president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the end of 2026, ending a decade leading one of Washington’s most influential drug industry groups. 9 April 2026
Pharmaceutical
US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) appears to have found a means of selecting members himself for a Centers for Disease Control and Prevention (CDC) vaccine advisory panel. 7 April 2026
Generics
In a dramatic move, the USA has announced a 100% tariff on all patented pharmaceutical imports, a decision aimed at bolstering domestic drug manufacturing and reducing reliance on foreign producers. 3 April 2026
Pharmaceutical
Nearly 8,000 clinical trial sites have been disrupted by the USA's escalating war on Iran, according to new analysis from clinical data firm Phesi, highlighting the fragility of globally distributed drug development. 2 April 2026
Pharmaceutical
US physician and biochemist Robert Malone has stepped down from the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices, after a federal court ruling derailed a contentious revamp of the panel. 30 March 2026
Pharmaceutical
The USA remains the outlier among wealthy drug markets. OECD data for 2023 put US retail pharmaceutical spending at $1,713 per person, against an OECD average of $766. Germany was at $1,158 and Switzerland at $1,061. 30 March 2026
Pharmaceutical
Disruption in the Gulf has tightened oil flows through the Strait of Hormuz, a route that typically carries about a quarter of global seaborne crude. Before the Iran war, around 20 million barrels a day moved through the strait. A sustained reduction affects not just fuel markets, but the wider industrial system built around them. 24 March 2026
Pharmaceutical
The Irish economy has performed extraordinarily well recently despite its high vulnerability to rising US protectionism. 23 March 2026
Pharmaceutical
A group of Senate Democrats has set out an expansive healthcare reform agenda, targeting rising insurance costs and insurer profits while positioning the effort as a response to recent Republican-led policy changes. 20 March 2026
Pharmaceutical
The US administration’s TrumpRx initiative and a proposed Medicare incentive rule link drug pricing, tariff policy, and domestic manufacturing in a coordinated push to reshore pharmaceutical production, highlighting shifting industry priorities, says intelligence and productivity platform GlobalData. 17 March 2026
Pharmaceutical
The US medicines regulator has provided an update on its work to address the country’s ongoing opioid epidemic, leveraging new powers granted in 2018 under the SUPPORT Act. 25 October 2019
Pharmaceutical
An important Congressional committee has approved House Speaker Nancy Pelosi’s pharmaceutical pricing bill, leading the way to further debate and an eventual vote in the US House of Representatives. 18 October 2019
Pharmaceutical
US trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has raised objections to a drug pricing plan outlined by House Speaker Nancy Pelosi. 11 October 2019
Pharmaceutical
The US National Institutes of Health (NIH) has awarded a grant of up to $4.6 million to Sydney University spinout Kinoxis Therapeutics, under an initiative aimed at combating the epidemic of opioid addiction in America. 30 September 2019
Pharmaceutical
A year after the US Government passed controversial “Right to Try” legislation, the first contract research organizations (CRO) are gearing up to provide people with access to experimental medicines. 18 September 2019
Pharmaceutical
More than $1.8 billion has been released by the US Department of Health and Human Services (HHS) to help combat the opioid crisis in the USA. 5 September 2019
Pharmaceutical
US President Donald Trump is reviving a stalled effort to compel drugmakers to list drug prices in direct to consumer (DTC) advertising, after a court struck down the initiative. 22 August 2019
Biotechnology
The recently-approved CAR-T therapies Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel) have come with a price tag to match the level of scientific innovation. 8 August 2019
Pharmaceutical
The US Department of Health and Human Services (HHS) and the country’s Food and Drug Administration (FDA) have announced a plan to import certain prescription drugs in order to lower prices for patients. 31 July 2019
Pharmaceutical
Shares in major pharmaceutical companies fell on Thursday, after the US government said it would abandon a proposal to require health insurers to pass significant rebates on to Medicare patients. 12 July 2019
Pharmaceutical
Last month, the US Department of Health and Human Services (HHS) announced a new rule demanding that direct-to-consumer television advertisements for certain pharmaceuticals and biologics state the list price of the medicine being advertised. 17 June 2019
Pharmaceutical
Amid multiple Congressional investigations into drug pricing in the USA, and a febrile political atmosphere around the role of the state in insurance and pricing negotiations, the nonpartisan Congressional Budget Office (CBO) released a report into so-called “Medicare for all” on Thursday. 2 May 2019
Pharmaceutical
US Health Secretary Alex Azar has outlined progress combating the ongoing opioid crisis, with an update one year on from a pledge from the US President to reduce unnecessary opioid prescriptions, expand treatment, and boost access to naloxone. 25 April 2019
Pharmaceutical
Representatives from pharmacy benefit managers (PBMs) were the latest to be grilled by lawmakers in Washington DC on Tuesday. 10 April 2019
Pharmaceutical
Most commercial executives in the industry thought the discussions over Obamacare were finally at an end, after a monthslong war of attrition between the White House and Congress early in Mr Trump’s presidency. They may need to think again. 27 March 2019
Pharmaceutical
The US Food and Drug Administration has announced new final guidance on HIV prevention, following US President Donald Trump’s recently-announced effort to eliminate the HIV epidemic within America. 20 March 2019
Pharmaceutical
Reflecting its growing standing as an opinion leader on all things drug price-related, the Institute for Clinical and Economic Review (ICER)—in collaboration with the Office of Health Economics (OHE) —has published a white paper looking at alternative models for pharmaceutical rebates in the USA. 13 March 2019
Pharmaceutical
US President Donald Trump recently promised a cheering Miami crowd that America "will never be a socialist country." Let's hope!, writes Institute for Policy Innovation (IPI) resident scholar Dr Merrill Mathews. 9 March 2019
Generics
Research shows some 79% of the American public view the cost of prescription drugs as unreasonable, and lawmakers and regulators are increasingly convinced the industry charges too much for its products. 8 March 2019
Pharmaceutical
In Washington DC on Tuesday, the chief executives of half a dozen leading drugmakers defended the industry’s drug pricing rationale and shifted the blame for high prices onto the sector’s intermediaries. 27 February 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze